Thus, CD103 appears to be a unique integrin for adjusting T-cell adhesion and migratory potential in a TGF-β-rich tumor microenvironment, as well as retention of tumor-specific CD8+ TRM cells and local antitumor effector functions (Figure 1). This evidence concerns the gene CD8A and neoplasm.